N-acetylcysteine (NAC)

Updated June 3, 2026

NAC refills the body's main intracellular antioxidant by feeding the rate-limiting substrate into the glutathione synthesis pathway. It does this so reliably that hospitals stock it as the antidote for acetaminophen overdose, and the WHO keeps it on the essential medicines list. The mechanism is simple. Cysteine is the bottleneck for glutathione production, and oral glutathione gets cleaved in the gut before it can reach cells. N-acetylcysteine sneaks the cysteine in, the liver rebuilds its glutathione pool, and the downstream antioxidant work resumes. Oral bioavailability is modest, somewhere around four to ten percent, but enough cysteine clears the gut to move clinical markers.

Glutathione is not just an antioxidant in the textbook sense. It is the substrate for glutathione peroxidase, which neutralizes hydrogen peroxide and lipid peroxides in the mitochondrial matrix where most cellular ROS is generated. It recycles oxidized vitamin C and vitamin E back to their active forms, which is why glutathione status quietly governs the rest of the antioxidant network. It conjugates electrophiles in phase II liver detoxification, the same chemistry that handles NAPQI in the acetaminophen rescue, and the same chemistry that clears a long list of everyday xenobiotics. NAC itself also scavenges peroxynitrite directly, which matters in inflamed vascular tissue where nitric oxide and superoxide combine into something more destructive than either.

The acetaminophen rescue is the cleanest demonstration of what NAC actually does. Started within roughly eight to ten hours of overdose, IV or oral NAC prevents the liver failure that paracetamol's toxic metabolite NAPQI would otherwise cause by stripping hepatic glutathione. The Prescott regimen runs grams on a fixed schedule. This is settled pharmacology, not a supplement claim. It tells you the substrate strategy works in the most demanding possible test: a poisoned liver running out of glutathione in real time.

Mucolytic use in COPD and cystic fibrosis is the other established lane. NAC breaks the disulfide bonds that hold mucus proteins together, thinning sputum so patients can clear it. PANTHEON, the 2014 Chinese COPD trial, showed a real reduction in exacerbation rates at 600 mg twice daily. The earlier 2005 BRONCUS trial (Decramer in the Lancet) had been mixed on lung function decline but flagged fewer exacerbations in patients not on inhaled steroids, which PANTHEON then confirmed. European guidelines treat NAC as a useful adjunct, especially for patients who are not already on inhaled corticosteroids. The anti-inflammatory layer underneath is real too. Restored glutathione dampens NF-kB signaling in airway epithelium, which lowers IL-6 and TNF-alpha output and reduces the inflammatory traffic that drives exacerbations in the first place. The mucus thinning is the visible effect. The cytokine quieting is the part you do not see.

The psychiatric signal is most consistent in OCD-spectrum disorders. Small trials at 2400 to 3000 mg per day have produced modest but reproducible improvements over placebo, and the 2009 Grant trial in trichotillomania at 1200 to 2400 mg daily reported a meaningful effect size that put NAC on the radar for compulsive grooming behaviors. Pediatric replications have been less impressive, and the bipolar and schizophrenia adjunct work is smaller and noisier, but the OCD/trichotillomania use case is a defensible target with a real mechanism: glutamate modulation in striatal circuits via the cystine-glutamate exchanger. NAC drives extrasynaptic glutamate up, which activates inhibitory mGluR2/3 autoreceptors and tones down the runaway glutamatergic firing that compulsive circuits seem to ride on. It is one of the few oral compounds with a credible handle on glutamate tone.

Contrast-induced nephropathy is where the story is genuinely contested. PRESERVE, the 2018 trial with over five thousand patients, found no benefit over placebo after angiography, and cardiology guidelines have moved on. Mention it, then move on too.

Typical supplement dosing is 600 to 1800 mg per day, split with food. The downside is real: NAC reeks of sulfur, something between rotten egg and old gym bag, and the burps can be worse than the capsule. Enteric coated capsules help. Effervescent forms, common in Europe as Fluimucil, mask the smell with citrus and are the easiest version to take consistently. Pick a target before you start: respiratory mucus clearance, an OCD-spectrum behavior, or substrate support for glutathione, and judge the bottle on whether the target moves.

Glycine is the natural comparison. It is the other amino acid that becomes rate-limiting for glutathione synthesis in older adults, and Sekhar's group at Baylor has built the GlyNAC protocol around pairing the two substrates at roughly equimolar doses. Their pilot work has reported improved glutathione levels, better insulin sensitivity, and movement on aging biomarkers including oxidative stress, mitochondrial fatty acid oxidation, inflammation markers, and grip strength. The biochemical logic is clean: older mitochondria leak more electrons, generate more ROS, and burn through glutathione faster, so the substrates that build it become rate-limiting again. Replacing them appears to restore mitochondrial membrane potential and ATP output in measurable ways. Trial sizes are still small, but the direction is consistent: unlock both rate-limiting steps at once rather than just one.

The immune angle is smaller but worth a sentence. Glutathione status governs T-cell function, and NAC has been studied as an adjunct in influenza and, more recently, in COVID-era trials with mixed but mechanistically plausible signals. Nothing approaching a settled indication. The substrate logic, again, is what it is.

A few practical cautions. NAC has mild antiplatelet activity and can potentiate nitroglycerin, sometimes dramatically, causing severe headaches and hypotension. Combining it with warfarin or other anticoagulants is not automatic disqualification but warrants attention. Asthmatic patients occasionally bronchospasm on inhaled NAC; oral is far gentler. GI upset and nausea are the everyday complaints. None of this is medical advice. If you take blood thinners, nitrates, or anything for blood pressure, or if you are pregnant, ask a clinician before adding NAC to the stack.

What you get from using NAC sensibly. A reliable way to feed the rate-limiting substrate into glutathione synthesis, which the acetaminophen literature proves actually works at the cellular level. Real reductions in COPD exacerbations at studied doses, especially off inhaled steroids. A useful tool for OCD-spectrum and trichotillomania symptoms in the published dose range. Quieter NF-kB signaling, restored phase II conjugation capacity, and a mitochondrial environment that holds together better as glutathione comes back online. And a clean, well-characterized substrate that pairs naturally with glycine if you want to push the glutathione system further. Pick the target, pick the dose, and the supplement earns its place.